bendamustine
Showing 1 - 25 of 149
Follicular Lymphoma Trial (Bendamustine, Rituximab, Tazemetostat)
Not yet recruiting
- Follicular Lymphoma
- Bendamustine
- +2 more
- (no location specified)
Sep 20, 2022
Mantle Cell Lymphoma, Non-hodgkin Lymphoma, Non Hodgkin Lymphoma Trial in Madison (Bendamustine, Obinutuzumab)
Recruiting
- Mantle Cell Lymphoma
- +2 more
- Bendamustine
- Obinutuzumab
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Mar 7, 2022
Chronic Lymphocytic Leucemia Trial in Cologne (Bendamustine, GA101, CAL-101)
Active, not recruiting
- Chronic Lymphocytic Leucemia
- Bendamustine
- +2 more
-
Cologne, GermanyGerman CLL Study Group
Apr 29, 2022
Relapsed T-Cell Lymphoma, Refractory T-Cell Lymphoma, Non Hodgkin Lymphoma Trial in Winston-Salem (CPI 613, Bendamustine)
Recruiting
- Relapsed T-Cell Lymphoma
- +2 more
- CPI 613
- Bendamustine
-
Winston-Salem, North CarolinaWake Forest Baptist Comprehensive Cancer Center
Aug 27, 2021
Mantle Cell Lymphoma Trial in Saint Louis (Bendamustine, Rituximab, Acalabrutinib)
Active, not recruiting
- Mantle Cell Lymphoma
- Bendamustine
- +7 more
-
Saint Louis, MissouriWashington University School of Medicine
Feb 2, 2022
Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma, Classical Hodgkin Lymphoma Trial in Atlanta (Bendamustine, Gemcitabine,
Active, not recruiting
- Recurrent Hodgkin Lymphoma
- +3 more
- Bendamustine
- +2 more
-
Atlanta, Georgia
- +1 more
Aug 25, 2021
Multiple Myeloma Trial in Berne (Melphalan, Bendamustine)
Completed
- Multiple Myeloma
- Melphalan
- Bendamustine
-
Berne, SwitzerlandDepartment for Medical Oncology University Hospital/Inselspital
Jul 29, 2021
Relapsed, Refractory, Multiple Myeloma Trial in Guangzhou (Pomalidomide, Bendamustine, Dexamethasone)
Not yet recruiting
- Relapsed, Refractory, Multiple Myeloma
- Pomalidomide
- +2 more
-
Guangzhou, Please Select, ChinaSun Yat-sen University Cancer Center
Feb 17, 2021
Leukemia, Lymphocytic, Chronic, B-Cell Trial in Austria (Bendamustine, Alemtuzumab)
Completed
- Leukemia, Lymphocytic, Chronic, B-Cell
- Bendamustine
- Alemtuzumab
-
Innsbruck, Tirol, Austria
- +6 more
Feb 15, 2022
Indolent Non-hodgkin Lymphoma Trial in München (Obinutuzumab, Bendamustine)
Active, not recruiting
- Indolent Non-hodgkin Lymphoma
- Obinutuzumab
- Bendamustine
-
München, Bavaria, GermanyKlinikum der Universität München
Jul 23, 2021
Chronic Lymphocytic Leucemia Trial in Cologne (Bendamustine, GA101, ABT-199)
Active, not recruiting
- Chronic Lymphocytic Leucemia
- Bendamustine
- +2 more
-
Cologne, GermanyGerman CLL Study Group
Aug 23, 2021
Waldenstrom Macroglobulinemia Trial in Canada (Acalabrutinib, Bendamustine, Rituximab)
Recruiting
- Waldenstrom Macroglobulinemia
- Acalabrutinib
- +2 more
-
Vancouver, British Columbia, Canada
- +3 more
Jul 23, 2021
Mantle Cell Lymphoma Trial in Boston (Rituximab, Bendamustine, Cytarabine)
Active, not recruiting
- Mantle Cell Lymphoma
- Rituximab
- +2 more
-
Boston, Massachusetts
- +2 more
Jun 9, 2021
Multiple Myeloma, CLL, Chronic Lymphocytic Leukemia Trial in Los Angeles (radiation, procedure, biological, drug)
Active, not recruiting
- Multiple Myeloma
- +4 more
- Total Body Irradiation
- +5 more
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Jul 15, 2022
Indolent Non-Hodgkin's Lymphoma, Follicular Lymphoma, Small Lymphocytic Lymphoma Trial in United States (Duvelisib, Placebo,
Withdrawn
- Indolent Non-Hodgkin's Lymphoma
- +3 more
- Duvelisib
- +3 more
-
Plainville, Connecticut
- +6 more
Mar 15, 2021
Multiple Myeloma, Chronic Kidney Disease Trial in United Kingdom (Bortezomib, Thalidomide, Bendamustine)
Completed
- Multiple Myeloma
- Chronic Kidney Disease
- Bortezomib
- +3 more
-
Basingstoke, United Kingdom
- +8 more
Jan 26, 2022
Lymphoma, Follicular Trial in United States (Bendamustine, Rituximab, Y-90 ibritumomab)
Completed
- Lymphoma, Follicular
- Bendamustine
- +2 more
-
Scarborough, Maine
- +3 more
Apr 27, 2021
Lymphatic Diseases Trial in Italy (Brentuximab Vedotin, Bendamustine)
Terminated
- Lymphatic Diseases
- Brentuximab Vedotin
- Bendamustine
-
Bologna, BO, Italy
- +4 more
May 26, 2021
Non-Hodgkin's Lymphoma Trial in Philadelphia (drug, procedure, genetic)
Active, not recruiting
- Non-Hodgkin's Lymphoma
- Bendamustine
- +6 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jun 3, 2021
Bendamustine, Multiple Myeloma Trial in Shenyang (Bendamustine)
Recruiting
- Bendamustine
- Multiple Myeloma
- Bendamustine
-
Shenyang, Liaoning, ChinaShengjing Hospital of China Medical University
Aug 7, 2021
Hodgkin's Lymphoma Trial in Poland (drug, diagnostic test, procedure)
Recruiting
- Hodgkin's Lymphoma
- Bendamustine
- +4 more
-
Bydgoszcz, Poland
- +12 more
Dec 23, 2021